Dextrose and Sodium Chloride NDC 17271-735

NDC codes

FDA NDC Directory

Product NDC (as listed)17271-735Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17271-0735Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
17271-735-06	17271073506	20 BAG in 1 CASE (17271-735-06) / 500 mL in 1 BAGMarketed from May 15, 2025
17271-735-07	17271073507	10 BAG in 1 CASE (17271-735-07) / 1000 mL in 1 BAGMarketed from May 15, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextrose and Sodium Chloride
Generic name (nonproprietary): dextrose monohydrate and sodium chloride
Active ingredients: Dextrose monohydrate — 5 g/100mLSodium chloride — .9 g/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: BECTON DICKINSON AND COMPANY
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211211
Marketing start: Oct 26, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)
Identifiers: Product ID 17271-735_69075560-be94-4804-ab7b-d8ebce41739aSPL ID 69075560-be94-4804-ab7b-d8ebce41739aSPL set ID c1d0f42e-3494-4217-8f86-e9f34d930e82RxCUI 1795344, 1795346UNII LX22YL083G, 451W47IQ8X
Pharmacologic class: Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N417271073506 followed by a unit qualifier and the quantity

Package 17271-0735-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 7, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211211

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211211
Product	Strength	Form · route	Labeler	Product NDC
Dextrose and Sodium Chloridedextrose monohydrate and sodium chloride	Dextrose monohydrate 5 g/100mL; Sodium chloride .9 g/100mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	63323-870